These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4089643)

  • 61. [Pattern of various hemodynamic parameters in ischemic heart disease and hypertension].
    Stasi-57nski T; Biryńczyk J; Lehmann Z; Rabiega J; Gross S
    Pol Tyg Lek; 1977 Aug; 32(34):1321-4. PubMed ID: 905176
    [No Abstract]   [Full Text] [Related]  

  • 62. Concepts leading to the development of an anti-ischemic drug. Introductory remarks.
    Godfraind T
    Arzneimittelforschung; 1979; 29(9a):1445. PubMed ID: 575488
    [No Abstract]   [Full Text] [Related]  

  • 63. Effects of verapamil on the acute experimental myocardial ischemia.
    Carp C; Pleşea O; Câmpeanu A
    Med Interne; 1980; 18(4):357-70. PubMed ID: 7455581
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cardiovascular effects of nifedipine--a 4-week treatment in preselected patients with coronary disease.
    Słomińska-Petelenz T; Petelenz T; Chruściel TL; Wilk J; Elertowicz M; Axenti I
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):122-7. PubMed ID: 7068285
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Contractile function of the myocardium during treatment of arteriosclerotic cardiosclerosis with methimazole].
    Neĭko EM; Vandzhura IP; Kupnovitskaia IG; Debenko MV
    Vrach Delo; 1978 Jun; (6):22-6. PubMed ID: 695463
    [No Abstract]   [Full Text] [Related]  

  • 66. [Protection of ischemic myocardium by verapamil (author's transl)].
    Nakamura Y; Hayashi J; Mori H; Ogawa S; Takahashi M; Hattori S; Ohosuzu F; Tanabe Y; Hara K
    Kokyu To Junkan; 1981 Apr; 29(4):399-403. PubMed ID: 7255989
    [No Abstract]   [Full Text] [Related]  

  • 67. Calcium channel blockers. New treatment for cardiovascular disease.
    Rossi LP; Antman EM
    Am J Nurs; 1983 Mar; 83(3):382-7. PubMed ID: 6550460
    [No Abstract]   [Full Text] [Related]  

  • 68. [Effect of heparin on certain biochemical and instrumental indicators in chronic ischemic heart disease].
    Neĭko EM; Vandzhura IP; Vasilevskiĭ VV; Debenko MV
    Vrach Delo; 1975 Sep; (9):28-30. PubMed ID: 1210292
    [No Abstract]   [Full Text] [Related]  

  • 69. [Intracardiac hemodynamics and myocardial contraction in patients with ischemic heart disease (echocardiographic data)].
    Furkalo NK; Shlykova NA; Lutaĭ M; Kuchuk AA; Zaĭtseva VI
    Ter Arkh; 1981; 53(12):11-4. PubMed ID: 7336331
    [No Abstract]   [Full Text] [Related]  

  • 70. Mechanism of action of verapamil in ischemic heart disease: observations on changes in systemic and coronary hemodynamics and coronary vasomobility.
    Chew CY; Brown BG; Singh BN; Hecht HS; Schnugg SJ; Wong M; Shah PM; Dodge HT
    Clin Invest Med; 1980; 3(1-2):151-8. PubMed ID: 7008996
    [No Abstract]   [Full Text] [Related]  

  • 71. [Heart failure in coronary heart disease].
    Hauf GF; Roskamm H
    Internist (Berl); 1993 Oct; 34(10):953-60. PubMed ID: 8225845
    [No Abstract]   [Full Text] [Related]  

  • 72. [Hemodynamic and coronary changes induced by various slow-channel inhibitors in chronic coronary insufficiency: nifedipine, verapamil and bepridil].
    Merillon JP; Duffloux MA; Eustigneff T; Pansard Y; Guiomard A; Zygelman M; Aumont MC; Gourgon R
    Therapie; 1981; 36(2):123-34. PubMed ID: 6270840
    [No Abstract]   [Full Text] [Related]  

  • 73. [Use of calcium antagonists in the therapy of coronary heart disease].
    Meyer J
    Internist (Berl); 1983 Jul; 24(7):408-14. PubMed ID: 6136492
    [No Abstract]   [Full Text] [Related]  

  • 74. [Adrenoreactivity of the contractile myocardium and coronary arteries in chronic overloading and acute ischemic damage to the heart].
    Bobkov IuI; Pimenova TI; Frolova TM; Shevliakova NI
    Patol Fiziol Eksp Ter; 1983; (2):8-11. PubMed ID: 6856362
    [No Abstract]   [Full Text] [Related]  

  • 75. [Acute hemodynamic effect of verapamil, used intravenously, in patients with primary dilated cardiomyopathy].
    Manfroi WC; Ludwig RT; Vieira SR; Goldim JR; Das SK; de Freitas FM; Faraco EZ
    Arq Bras Cardiol; 1985 Nov; 45(5):371-5. PubMed ID: 3915860
    [No Abstract]   [Full Text] [Related]  

  • 76. [Surgical treatment of ischemic heart disease with complete coronary artery occlusions].
    Burakovskiĭ VI; Rabotnikov VS; Vasilidze TV; Kazakov EN; Kertsman VP
    Grudn Khir; 1980; 4():5-9. PubMed ID: 6967441
    [No Abstract]   [Full Text] [Related]  

  • 77. Verapamil in treatment of chronic stable angina.
    Frishman WH; Charlap S
    Arch Intern Med; 1983 Jul; 143(7):1407-15. PubMed ID: 6135403
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Attenuation of the negative inotropic effects of metoprolol at short cycle lengths in humans: comparison with sotalol and verapamil.
    Ritchie RH; Zeitz CJ; Wuttke RD; Hii JT; Horowitz JD
    J Am Coll Cardiol; 2006 Sep; 48(6):1234-41. PubMed ID: 16979012
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Effect of hemosorption on central and intracardiac hemodynamics in patients with chronic ischemic heart disease].
    Topchin II; Volkov VI; Nikolay AG; Kleshchevnikova LL; Gladchenko AR
    Vrach Delo; 1988 Jun; (6):10-2. PubMed ID: 3420892
    [No Abstract]   [Full Text] [Related]  

  • 80. [Right ventricular function in ischemic heart disease].
    Horák J; Fabián J; Ouhrabková R
    Cas Lek Cesk; 1987 Jan; 126(2):44-9. PubMed ID: 3802162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.